COVID-19 Vaccine Manufacturing Capacity

KEI has created a public listserve to discuss vaccine manufacturing scale up. (link)

February 19, 2021: Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 Vaccines – 19.

KEI has gathered data regarding vaccine manufacturing capacity in countries worldwide, across different vaccine technology platform, as well as on the outsourcing of manufacturing.

Selected SEC filings of interest

KEI has also compiled articles regarding the Oxford/AstraZeneca COVID-19 vaccine and the role of Gates in the exclusive licensing decision. “Notes and references to some of the new stories about the Gates role in Oxford granting an exclusive license.